{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:09Z","timestamp":1793330109452,"version":"4.5.0"},"reference-count":174,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The management of chronic obstructive pulmonary disease (COPD) has improved significantly due to advances in therapeutic agents, but it has also become apparent that there are issues that remain difficult to solve with the current treatment algorithm. COPD patients face a number of unmet needs concerning symptoms, exacerbations, and physical inactivity. There are various risk factors and triggers for these unmet needs, which can be roughly divided into two categories. One is the usual clinical characteristics for COPD patients, and the other is specific clinical characteristics in patients with comorbid conditions, such as asthma, cardiovascular disease, and bronchiectasis. These comorbidities, which are also associated with the diversity of COPD, can cause unmet needs resistance to usual care. However, treatable conditions that are not recognized as therapeutic targets may be latent in patients with COPD. We again realized that treatable traits should be assessed and treated as early as possible. In this article, we categorize potential therapeutic targets from the viewpoint of pulmonary and systemic comorbid conditions, and address recent data concerning the pathophysiological link with COPD and the impact of intervention on comorbid conditions in order to obtain evidence that could enable us to provide personalized COPD management.<\/jats:p>","DOI":"10.3390\/jcm9103078","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:33:03Z","timestamp":1600936383000},"page":"3078","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0514-3241","authenticated-orcid":false,"given":"Kazuto","family":"Matsunaga","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Suizu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-0450","authenticated-orcid":false,"given":"Keiji","family":"Oishi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Asami-Noyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-0806","authenticated-orcid":false,"given":"Tsunahiko","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(04)16855-4","article-title":"Burden and clinical features of chronic obstructive pulmonary disease (COPD)","volume":"364","author":"Pauwels","year":"2004","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/09031936.06.00024505","article-title":"Epidemiology and costs of chronic obstructive pulmonary disease","volume":"27","author":"Chapman","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_3","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (2020, June 01). 2020 Report: Global Strategy for Prevention, Diagnosis and Management of COPD. Available online: https:\/\/goldcopd.org\/gold-reports\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pupt.2017.12.005","article-title":"Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease","volume":"49","author":"Donohue","year":"2018","journal-title":"Plum. Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease pnenotypes. The future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/COPD.S84134","article-title":"Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease","volume":"10","author":"Minakata","year":"2015","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2018.05.001","article-title":"The Challenge of controlling the COPD epidemic: Unmet needs","volume":"131","author":"Polverino","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2147\/COPD.S175706","article-title":"Personalized medicine for patients with COPD: Where are we?","volume":"14","author":"Franssen","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/COPD.S219051","article-title":"Time to revise COPD treatment algorithm","volume":"14","author":"Matsunaga","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2147\/COPD.S188141","article-title":"Activity-related dyspnea in chronic obstructive pulmonary disease: Physical and psychological consequences, unmet needs, and future directions","volume":"14","author":"Hanania","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra1900500","article-title":"Update on clinical aspects of chronic obstructive pulmonary disease","volume":"381","author":"Celli","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","article-title":"Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease","volume":"195","author":"Dransfield","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.amjmed.2018.05.003","article-title":"Chronic obstructive pulmonary disease exacerbations: A need for action","volume":"131","author":"Anzueto","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.resinv.2014.10.006","article-title":"Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: A multicenter cross-sectional CAP study","volume":"53","author":"Matsunaga","year":"2015","journal-title":"Respir. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.2147\/COPD.S181938","article-title":"Characteristics of 2017 GOLD COPD group A: A multicenter cross-sectional CAP study in Japan","volume":"13","author":"Oishi","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2011.00036","article-title":"Improvement of Airflow Limitation by Fluticasone Propionate\/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?","volume":"2","author":"Akamatsu","year":"2011","journal-title":"Front. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"026007","DOI":"10.1088\/1752-7163\/ab71a4","article-title":"Detection of type2 biomarkers for response in COPD","volume":"14","author":"Yamaji","year":"2020","journal-title":"J. Breath Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/thx.2007.081893","article-title":"Use of \u03b2 blockers and the risk of death in hospitalised patients with acute exacerbations of COPD","volume":"63","author":"Dransfield","year":"2007","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Du, Q., Sun, Y., Ding, N., Lu, L., and Chen, Y. (2014). Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: A meta-analysis of observational studies. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113048"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(15)00509-3","article-title":"Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease","volume":"4","author":"MacDonald","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pupt.2014.05.002","article-title":"Antibiotic prophylaxis in COPD: Why, when, and for whom?","volume":"32","author":"Miravitlles","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-208599","article-title":"Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung","volume":"72","author":"Segal","year":"2017","journal-title":"Thorax"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lopez-Campos, J.L., Miravitlles, M., de la Rosa Carrillo, D., Canton, R., Soler-Cataluna, J.J., and Martinez-Garcia, M.A. (2020). Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease. J. Clin. Med., 28.","DOI":"10.3390\/jcm9061639"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD. Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Respir. Med."},{"key":"ref_26","first-page":"30145","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"20","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/resp.13633","article-title":"Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology","volume":"24","author":"Rhee","year":"2019","journal-title":"Respirology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Martinez-Garcia, M.A., de la Rosa-Carrillo, D., Soler-Cataluna, J.J., Catalan-Serra, P., Ballester, M., Roca Vanaclocha, Y., Agramunt, M., Ballestin, J., Garcia-Ortega, A., and Oscullo, G. (2020). Bronchial infection and temporal evolution of bronchiectasis in patients with chronic obstructive pulmonary disease. Clin. Infect. Dis., in press.","DOI":"10.1093\/cid\/ciaa069"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1183\/09031936.00208011","article-title":"Macrolide effects on the prevention of COPD exacerbations","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","article-title":"Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis","volume":"68","author":"Andrejak","year":"2013","journal-title":"Thorax"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","article-title":"Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group","volume":"153","author":"Vestbo","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09059180.00003610","article-title":"Mucoactive therapy in COPD","volume":"19","author":"Decramer","year":"2010","journal-title":"Eur. Respir. Rev"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Poole, P., Chong, J., and Cates, C.J. (2015). Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., CD001287.","DOI":"10.1002\/14651858.CD001287.pub5"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: A European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/15412555.2016.1254172","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and risk of pneumonia: A nested case-control population-based study in Lazio (Italy)-the outpul study","volume":"14","author":"Cascini","year":"2017","journal-title":"COPD"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"eaav3879","DOI":"10.1126\/scitranslmed.aav3879","article-title":"Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease","volume":"11","author":"Singanayagam","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1700451","DOI":"10.1183\/13993003.00451-2017","article-title":"Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD","volume":"50","author":"Contoli","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.201908-1550OC","article-title":"Inhaled steroids, circulating eosinophils, chronic airway infection and pneumonia risk in chronic obstructive pulmonary disease: A network analysis","volume":"201","author":"Faner","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.200402-230OC","article-title":"Decline in lung function in the Busselton Health Study: The effects of asthma and cigarette smoking","volume":"171","author":"James","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaci.2006.07.053","article-title":"Mild to moderate asthma affects lung growth in children and adolescents","volume":"118","author":"Strunk","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1164\/rccm.201110-1922OC","article-title":"Interaction between asthma and lung function growth in early life","volume":"185","author":"Bisgaard","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.200504-525OC","article-title":"Outcome of asthma and wheezing in the first 6 years of life: Follow-up through adolescence","volume":"172","author":"Morgan","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJMoa052885","article-title":"Reduced lung function at birth and the risk of asthma at 10 years of age","volume":"355","author":"Carlsen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa022363","article-title":"A longitudinal, population-based, cohort study of childhood asthma followed to adulthood","volume":"349","author":"Sears","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: A prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"J. Asthma"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-14-10","article-title":"Atopy is a risk factor for respiratory symptoms in COPD patients: Results from the EUROSCOP study","volume":"14","author":"Fattahi","year":"2013","journal-title":"Respir. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.201211-2103OC","article-title":"Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease","volume":"188","author":"Jamieson","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study","volume":"193","author":"Nielsen","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1701457","DOI":"10.1183\/13993003.01457-2017","article-title":"Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD","volume":"51","author":"Agusti","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1702536","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ageing\/afq134","article-title":"Multidimensional assessment of older people with asthma and COPD: Clinical management and health status","volume":"40","author":"McDonald","year":"2011","journal-title":"Age Ageing"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.07-2317","article-title":"Burden of concomitant asthma and COPD in a Medicaid population","volume":"134","author":"Shaya","year":"2008","journal-title":"Chest"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2147\/COPD.S88274","article-title":"Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations","volume":"10","author":"Tamada","year":"2015","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12931-014-0130-1","article-title":"The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function","volume":"15","author":"Jin","year":"2014","journal-title":"Respir. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1183\/09031936.00162912","article-title":"Aspergillus fumigatus during stable state and exacerbations of COPD","volume":"43","author":"Bafadhel","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_64","first-page":"A2546","article-title":"Biomarker-Based Detection of Type-2 Inflammation in COPD Patients","volume":"201","author":"Oishi","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: Analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(18)30327-8","article-title":"Triple therapy with budesonide\/glycopyrrolate\/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): A double-blind, parallel-group, multicentre, phase 3 randomised controlled trial","volume":"6","author":"Ferguson","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: A post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/rccm.201803-0405OC","article-title":"Long-Term Triple Therapy De-escalation to Indacaterol\/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial","volume":"198","author":"Chapman","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/COPD.S129321","article-title":"Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD","volume":"12","author":"Song","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/pds.4655","article-title":"Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality","volume":"27","author":"Oshagbemi","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.chest.2019.04.012","article-title":"Stability of the Blood Eosinophilic Phenotype in Stable and Exacerbated COPD","volume":"156","author":"Schumann","year":"2019","journal-title":"Chest"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pop.2016.07.010","article-title":"Eosinophilia","volume":"43","author":"Kovalszki","year":"2016","journal-title":"Prim Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.alit.2018.01.002","article-title":"Definition and diagnosis of asthma-COPD overlap (ACO)","volume":"67","author":"Yanagisawa","year":"2018","journal-title":"Allergol Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the Prevention of COPD Exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.2203046","article-title":"Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease","volume":"167","author":"Sanders","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","article-title":"Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study","volume":"3","author":"Heinzer","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2147\/COPD.S4950","article-title":"Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences","volume":"3","author":"Paz","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5664\/jcsm.8466","article-title":"The Risk of Cardiovascular and Cerebrovascular Disease in Overlap Syndrome: A Meta-Analysis","volume":"16","author":"Xu","year":"2020","journal-title":"J. Clin. Sleep Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1513\/AnnalsATS.201802-136OC","article-title":"Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome)","volume":"16","author":"Kendzerska","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1183\/09059180.00004311","article-title":"Night-time symptoms: A forgotten dimension of COPD","volume":"20","author":"Agusti","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","article-title":"Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome","volume":"182","author":"Marin","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15412555.2020.1715361","article-title":"Nasal High Flow Use in COPD Patients with Hypercapnic Respiratory Failure: Treatment Algorithm & Review of the Literature","volume":"17","author":"Pantazopoulos","year":"2020","journal-title":"COPD"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.107.5.1193","article-title":"Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure","volume":"107","author":"Weitzenblum","year":"1995","journal-title":"Chest"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1183\/09059180.00007913","article-title":"The vascular bed in COPD: Pulmonary hypertension and pulmonary vascular alterations","volume":"23","author":"Sakao","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.08-2306","article-title":"Idiopathic pulmonary fibrosis and emphysema: Decreased survival associated with severe pulmonary arterial hypertension","volume":"136","author":"Carrillo","year":"2009","journal-title":"Chest"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/0003-4819-102-1-29","article-title":"Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease","volume":"102","author":"Timms","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/arrd.1985.131.4.493","article-title":"Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"131","author":"Weitzenblum","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"Blanco","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_93","first-page":"309","article-title":"Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: A systematic review and meta-analysis","volume":"7","author":"Chen","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/resp.12530","article-title":"Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases","volume":"20","author":"Tanabe","year":"2015","journal-title":"Respirology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: Results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"180057","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: Dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","article-title":"Chronic obstructive pulmonary disease and cardiovascular disease","volume":"162","author":"Bhatt","year":"2013","journal-title":"Transl. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/thoraxjnl-2017-210865","article-title":"Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: A population-based study using UK primary care data","volume":"73","author":"Morgan","year":"2018","journal-title":"Thorax"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jacc.2018.06.049","article-title":"Declining Lung Function and Cardiovascular Risk: The ARIC Study","volume":"72","author":"Silvestre","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","article-title":"Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study","volume":"21","author":"Buch","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1753465817750524","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: What are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","article-title":"Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial","volume":"198","author":"Kunisaki","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000448166","article-title":"Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial","volume":"136","author":"Canepa","year":"2017","journal-title":"Cardiology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/eurheartj\/ehi291","article-title":"Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease","volume":"26","author":"Rutten","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e008225","DOI":"10.1136\/bmjopen-2015-008225","article-title":"Extended prediction rule to optimise early detection of heart failure in older persons with non-acute shortness of breath: A cross-sectional study","volume":"6","author":"Hoes","year":"2016","journal-title":"BMJ. Open"},{"key":"ref_109","first-page":"55","article-title":"Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study","volume":"11","author":"Kostikas","year":"2020","journal-title":"Pragmat. Obs. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/heartjnl-2014-307251","article-title":"Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease","volume":"101","author":"Rothnie","year":"2015","journal-title":"Heart"},{"key":"ref_111","unstructured":"Brunton, L.L., Hilal-Dandon, R., and Knollman, B.C. (2018). Goodman & Gilman\u2019s Pharmacological Basis of Therapeutics, McGraw Hill. [13th ed.]."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0954-6111(11)70010-5","article-title":"Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized trial","volume":"105","author":"Lainscak","year":"2011","journal-title":"Respir. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/COPD.S79942","article-title":"Impact of \u03b2-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease","volume":"10","author":"Kubota","year":"2015","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2147\/COPD.S141694","article-title":"The evaluation of \u03b2-adrenoceptor blocking agents in patients with COPD and congestive heart failure: A nationwide study","volume":"12","author":"Liao","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1908142","article-title":"Metoprolol for the Prevention of Acute Exacerbations of COPD","volume":"381","author":"Dransfield","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1164\/rccm.201805-0995OC","article-title":"Effect of Indacaterol\/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial","volume":"199","author":"Kaireit","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2213-2600(18)30054-7","article-title":"Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): A double-blind, randomised, crossover, placebo-controlled, single-centre trial","volume":"6","author":"Hohlfeld","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.02.00532002","article-title":"Prognostic value of weight change in chronic obstructive pulmonary disease: Results from the Copenhagen City Heart Study","volume":"20","author":"Prescott","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1702146","DOI":"10.1183\/13993003.02146-2017","article-title":"Emphysema and extrapulmonary tissue loss in COPD: A multi-organ loss of tissue phenotype","volume":"51","author":"Celli","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/ajrccm\/147.5.1151","article-title":"Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation","volume":"147","author":"Schols","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1183\/09031936.00070914","article-title":"Nutritional assessment and therapy in COPD: A European Respiratory Society statement","volume":"44","author":"Schols","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1164\/ajrccm.157.6.9705017","article-title":"Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease","volume":"157","author":"Schols","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.160.6.9902115","article-title":"Prognostic value of nutritional status in chronic obstructive pulmonary disease","volume":"160","author":"Landbo","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Ji, Z., de Miguel-D\u00edez, J., Castro-Riera, C.R., Bell\u00f3n-Cano, J.M., Gallo-Gonz\u00e1lez, V., Gir\u00f3n-Matute, W.I., Jim\u00e9nez-Garc\u00eda, R., L\u00f3pez-de Andr\u00e9s, A., Moya-\u00c1lvarez, V., and Puente-Maestu, L. (2020). Differences in the outcome of patients with COPD according to body mass index. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030710"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.rmed.2015.06.009","article-title":"Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease","volume":"109","author":"Benson","year":"2015","journal-title":"Respir. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00405-009-0922-y","article-title":"Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease","volume":"266","author":"Eryuksel","year":"2009","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.119.4.1043","article-title":"Increased prevalence of gastroesophageal reflux symptoms in patients with COPD","volume":"119","author":"Mokhlesi","year":"2001","journal-title":"Chest"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thx.2007.092858","article-title":"Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation","volume":"63","author":"Terada","year":"2008","journal-title":"Thorax"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-15-62","article-title":"COPDGene Investigators. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort","volume":"15","author":"Martinez","year":"2014","journal-title":"Respir. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1164\/ajrccm.161.1.9808014","article-title":"Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics","volume":"161","author":"Cuttitta","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1378\/chest.09-0482","article-title":"Abnormal swallowing reflex and COPD exacerbations","volume":"137","author":"Terada","year":"2010","journal-title":"Chest"},{"key":"ref_134","first-page":"2498","article-title":"Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease","volume":"59","author":"Gadel","year":"2012","journal-title":"Hepato-Gastroenterol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1532-5415.2009.02349.x","article-title":"A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients","volume":"57","author":"Sasaki","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/resp.12758","article-title":"Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD","volume":"21","author":"Baumeler","year":"2016","journal-title":"Respirology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.201003-0472OC","article-title":"Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort","volume":"183","author":"Hanania","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_138","first-page":"1289","article-title":"Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease","volume":"9","author":"Panagioti","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rmed.2016.06.006","article-title":"Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies","volume":"117","author":"Matte","year":"2016","journal-title":"Respir. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1378\/chest.15-0449","article-title":"Association of psychological disorders with 30-Day readmission rates in patients with COPD","volume":"149","author":"Singh","year":"2016","journal-title":"Chest"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archinte.167.1.60","article-title":"Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life","volume":"167","author":"Ng","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1183\/09031936.00163913","article-title":"Impact of symptoms of anxiety and depression on COPD Assessment Test scores","volume":"43","author":"Hilmarsen","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.chest.2019.04.009","article-title":"Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: A systematic review and meta-analysis","volume":"156","author":"Gordon","year":"2019","journal-title":"Chest"},{"key":"ref_144","first-page":"CD012346","article-title":"Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease","volume":"12","author":"Pollok","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1164\/rccm.201402-0373ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update on limb muscle dysfunction in chronic obstructive pulmonary disease","volume":"189","author":"Maltais","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thoraxjnl-2014-206440","article-title":"Sarcopenia in COPD: Prevalence, clinical correlates and response to pulmonary rehabilitation","volume":"70","author":"Jones","year":"2015","journal-title":"Thorax"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/COPD.S130790","article-title":"Sarcopenia correlates with systemic inflammation in COPD","volume":"12","author":"Byun","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0838.2007.00712.x","article-title":"Effect of strength training on muscle function in elderly hospitalized patients","volume":"17","author":"Suetta","year":"2007","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/ajrccm.153.1.8542131","article-title":"Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD","volume":"153","author":"Maltais","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Matsunaga, K. (2014). Oxidative stress and respiratory muscle. Studies on Respiratory Disorders, Oxidative Stress in Applied Basic ReseArch and Clinical Practice, Springer Humana Press.","DOI":"10.1007\/978-1-4939-0497-6_13"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Sayer","year":"2019","journal-title":"Lancet"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","article-title":"Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia","volume":"33","author":"Biolo","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.chest.2018.02.014","article-title":"The relationship between COPD and frailty: A systematic review and meta-analysis of observational Studies","volume":"154","author":"Marengoni","year":"2018","journal-title":"Chest"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.hrtlng.2012.07.004","article-title":"Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003\u20132006)","volume":"42","author":"Park","year":"2013","journal-title":"Heart Lung"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2011.06.024","article-title":"Frailty and respiratory impairment in older persons","volume":"125","author":"Enright","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1753465817726314","article-title":"Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: A longitudinal study","volume":"11","year":"2017","journal-title":"Ther. Adv Respir. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archinte.166.4.418","article-title":"Transitions between frailty states among community-living older persons","volume":"166","author":"Gill","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/thoraxjnl-2016-208460","article-title":"Physical frailty and pulmonary rehabilitation in COPD: A prospective cohort study","volume":"71","author":"Maddocks","year":"2016","journal-title":"Thorax"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Bernabeu-Mora, R., Oliveira-Sousa, S.L., Sanchez-Martinez, M.P., Garcia-Vidal, J.A., Gacto-Sanchez, M., and Medina-Mirapeix, F. (2020). Frailty transitions and associated clinical outcomes in patients with stable COPD: A longitudinal study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230116"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1183\/13993003.01699-2014","article-title":"Benefits of physical activity on COPD hospitalization depend on intensity","volume":"46","author":"Balcells","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1164\/rccm.200407-855OC","article-title":"Characteristics of physical activities in daily life in chronic obstructive pulmonary disease","volume":"171","author":"Pitta","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2147\/COPD.S109694","article-title":"Differences in physical activity according to mMRC grade in patients with COPD","volume":"11","author":"Hayata","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000330046","article-title":"Validation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary disease","volume":"83","author":"Sugino","year":"2012","journal-title":"Respiration"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2147\/COPD.S208081","article-title":"Effect of tiotropium\/olodaterol on sedentary and active time in patients with COPD: Post hoc analysis of the VESUTO study","volume":"14","author":"Minakata","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/rccm.201706-1288OC","article-title":"Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease","volume":"198","author":"Troosters","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.resinv.2018.12.001","article-title":"Combination of assist use of short-acting beta-2 agonists inhalation and guidance based on patient-specific restrictions in daily behavior: Impact on physical activity of Japanese patients with chronic obstructive pulmonary disease","volume":"57","author":"Hirano","year":"2019","journal-title":"Respir. Investig."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/gerona\/gls191","article-title":"Motoric cognitive risk syndrome and the risk of dementia","volume":"68","author":"Verghese","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"101022","DOI":"10.1016\/j.arr.2020.101022","article-title":"Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults","volume":"58","author":"Semba","year":"2020","journal-title":"Aging Res. Rev."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Hirano, T., Doi, K., Matsunaga, K., Takahashi, S., Donishi, T., Suga, K., Oishi, K., Yasuda, K., Mimura, Y., and Harada, M. (2020). A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092737"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Matsunaga, K., Kuwahira, I., Hanaoka, M., Saito, J., Tsuburai, T., Fukunaga, K., Matsumoto, H., Sugiura, H., and Ichinose, M. (2020). An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice. Respir. Investig.","DOI":"10.1016\/j.resinv.2020.05.006"},{"key":"ref_174","first-page":"443","article-title":"Consensus on the Asthma\u2013COPD Overlap (ACO) between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)","volume":"53","author":"Plaza","year":"2017","journal-title":"Arch. Bronchoneumol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3078\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:13:13Z","timestamp":1760177593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/10\/3078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":174,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["jcm9103078"],"URL":"https:\/\/doi.org\/10.3390\/jcm9103078","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}